This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here

Longevity/mortality Buy-Ins, Buy-Outs, Longevity Bonds, Pandemics

Analysis

NN's Jan-Hendrik Erasmus: "the key issue is how to embrace technology"

NN Group’s chief risk officer discusses with David Walker how the Dutch insurer is positioned for M&A, why Solvency II does not need to change, longevity risk hedging and today’s technology and cyber challenges

Gen Re's Jules Constantinou: technology can make insurance more meaningful

Jules Constantinou, regional manager for life and health at GenRe UK and Ireland, and president-elect of the Institute and Faculty of Actuaries, vows to make insurance more meaningful to society. He tells Cintia Cheong how technology can help achieve that

Declining UK influence suggests far-reaching Solvency II reforms

National supervisors argue that looming reviews of the standard formula and the long-term guarantees package could be wider than expected now the UK has voted to leave the EU. Hugo Coelho reports

Unfreezing the UFR

The revised methodology for calculating the ultimate forward rate may not be a catastrophe for all insurers with long-term liabilities, but it will put an unwelcome spotlight on solvency and accelerate the redesign of products. Hugo Coelho reports

Valuation issues persist for PPOs

Periodical payment orders may be an established part of the UK motor insurance claims landscape but methods for reserving for them are still uncertain, as Rob Treen explains

Germany hits the brakes on its €32bn ZZR

The ballooning level of additional interest rate reserves has prompted reforms to the rules, but few insurers took advantage in 2015. Hugo Coelho reports